Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Onconova Therapeutics (ONTX Research Report) and Biogen...
Translational science to characterize pathways impacted by rigosertib may help to guide future clinical studies and combination treatment regimen for difficult-to-treat cancersNEWTOWN, Pa., March...
Onconova Therapeutics, Inc. (NASDAQ:ONTX Get Free Report) was the recipient of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling...